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Introduction
With one-third of the world’s population infected with 
Myobacterium tuberculosis (M. tuberculosis), tuberculosis (TB) 
remains a major threat to public health.1 Although much is 
known about the immunology of TB, the precise nature of the 
protective immune mechanisms against the tubercle bacillus has 
not been completely defined. Nevertheless, existing evidence 
suggest that cellular Th1-mediated immunity plays a critical role 
in host defense against M. tuberculosis. The protective role of Th1 
cell-mediated immune response in TB is perhaps best illustrated 
by the enhanced susceptibility to M. tuberculosis in individuals 
with human immunodeficiency virus (HIV) infection, a disease 
characterized by profound loss of CD4 T cells, including the 
Th1 subtype.2
Pathogens induce apoptosis of macrophages3 and T cells4,5 
for enhancing their survival in the host and also as a means of 
evading host immune response. Studies designed to examine 
the significance of apoptosis in tuberculosis have focused on 
macrophages, the primary host cell of the tubercle bacillus, and 
also on T cells, the primary effector cell mediating protection. 
Although it remains to be proven definitively, these research 
efforts have collectively yielded the hypothesis that apoptosis 
of M. tuberculosis-infected macrophages may constitute a 
host defense mechanism against the tubercle bacillus.6,7 M. 
tuberculosis has evolved strategies to inhibit macrophage 
apoptosis for its survival,8 and virulent strains evade apoptosis of 
infected alveolar macrophages.9 The recognition of the presence 
of antiapoptotic genes in the genome of M. tuberculosis is a strong 
evidence that induction of macrophage death is an immune 
evasion strategy for this pathogen.10 Enhanced apoptosis of 
macrophages, however, is also important for initiating adaptive 
immunity to M. tuberculosis in the host.11 Indeed inactivation 
in M. tuberculosis of a gene that encodes a component of a 
virulence-associated protein secretion system (secA2) resulted 
in enhanced macrophage apoptosis and increased priming of 
adaptive immunity to M. tuberculosis.12
In contrast to the role of macrophage apoptosis as a host 
defense mechanism, apoptosis of T cells seen in murine13,14 and 
human15 TB may instead attenuate the host immune response 
to M. tuberculosis. Given the significance of Th1 immunity in 
host defense against M. tuberculosis, it is not unreasonable to 
postulate that the tubercle bacillus, notorious for persistence 
in the host, may have evolved mechanisms to attenuate the 
protective Th1 immune response during tuberculous infection. 
Indeed, T cell hyporesponsiveness has long been recognized 
in individuals with acute TB. In humans, it has long been 
known that apoptosis occurs in tuberculous tissues.16,17 In in 
vitro studies using peripheral blood mononuclear cells from 
tuberculous patients,18 the well-described phenomenon of T 
cell hyporesponsiveness has been linked to spontaneous or M. 
tuberculosis-induced apoptosis of T cells. The observed apoptosis 
is associated with diminished M. tuberculosis-stimulated 
IFN-γ and IL-2 production. A relationship of Th1 apoptosis 
to disease progression is also demonstrated in mice infected 
with virulent M. tuberculosis.19 These results therefore suggest 
that apoptotic pathways operative during tuberculous infection 
could lead to the depletion of M. tuberculosis-reactive T cells, 
thereby contributing to the immunopathogenesis of TB. A 
detailed analysis of paraformaldehyde-fixed human tuberculous 
tissues revealed that apoptotic CD3+ and CD45RO+ (a marker 
of T-cell activation) cells are present in productive tuberculous 
granulomas, particularly those harboring a necrotic center.20
The objective of the present study was to examine the 
mechanism behind the enhanced Th1 apoptosis that occurs at 
sites of active M. tuberculosis infection.
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In this study, we compared several immune parameters in tuberculosis (TB) and nontuberculosis (NTB) pleurisy to gain an understanding 
of the mechanism behind enhanced Th1 apoptosis that occurs at sites of active Myobacterium tuberculosis (M. tuberculosis) infection. 
An initial evaluation of the accumulated cytokines in pleural fluid (PF) demonstrated that both TB and NTB pleurisy were associated 
with proinflammatory cytokines, while only TB pleurisy had augmented expression of interferon (IFN)-γ and soluble Fas ligand (sFASL). 
Despite enhanced expression of the apoptosis-inducing molecule in TB pleurisy, T cells derived from both types of pleurisy exhibited 
significant apoptosis. In both groups, T-cell apoptosis correlated with low expression of CD80 on PF-derived macrophages and elevated 
accumulation of TGF-b in the PF. A causative correlation between TGF-b and low CD80 expression in the two groups was established 
by in vitro studies demonstrating TGF-b inhibition of CD80 upregulation in a macrophage cell line. Together, the findings allude to the 
possibility that activation in the absence of appropriate CD80 costimulation is the mechanism that leads to T-cell apoptosis at sites of 
active M. tuberculosis infection. Furthermore, the findings also indicate that T-cell apoptosis is perhaps a host regulatory mechanism to 
limit inflammation, rather than a pathogen-induced immune deviation.
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Materials, Study Populations, and Methods
Patient population
During the study period, 45 patients with pleural effusions 
were recruited from the Government General Hospital (GGH), 
Chennai. Clinical signs and symptoms, demographic data, and 
radiologic results were recorded. The patients recruited were newly 
diagnosed for pleural involvement with normal immune function 
and were not relapsed cases. The age of these patients varied from 
20 to 75 years. These patients were found to be seronegative for 
HIV and were grouped into tuberculous (TB) and nontuberculous 
(NTB) pleuritis based on various diagnostic criteria.
The TB group consisted of 27 patients (19 men and 18 
women; average age 36 years; range 19–65 years) with lymphocyte 
predominance exudative effusions. The diagnosis for tuberculosis 
was on the basis of positivity to any two of the following criteria: (i) 
smear positivity for sputum/pleural fluid (PF) for M. tuberculosis 
(Ziehl–Neelson method), (ii) culture positivity for the growth 
of M. tuberculosis on Lowenstein–Jensen medium, (iii) clinical 
picture that include chest X-ray and clinical symptoms for 
tuberculosis, (iv) PCR positivity for the presence of insertion 
sequence IS6110 specific for M. tuberculosis, and (v) favorable 
response to antituberculosis treatment (ATT) during the first3 
months of follow-up period. The samples were collected before 
the start of the treatment.
The NTB group consisted of 18 patients (15 men and 2 
women; average age 52 years; range 25–75 years) with pleural 
effusions due to malignancy, congestive cardiac failure, and liver 
disorders. The exudative effusion with lymphocytic predominance 
was found in malignancy cases, whereas transudative effusion 
was observed in cardiac, hepatic, and kidney failure cases and in 
secondary infection in systemic lupus erythematosis (SLE). The 
PFs or bronchoscopy specimens were subjected to cytological/
histology examination for malignant cells and/or other etiology. 
Other cases were diagnosed on the basis of their compatible 
clinical presentation and radiological findings. When no diagnosis 
could be made with all available information, the effusion was 
deemed idiopathic. The diagnosis was retrospectively proven as 
the disease was cured following the appropriate therapy.
The study was approved by the institutional ethical committee 
of Tuberculosis Research Centre (study number TRC/2003/7/
Imm/4), Chennai, and followed the ethical guidelines of GGH, 
Chennai. A written and informed consent was obtained from each 
patient. An approval was also obtained from the institutional review 
board at the University of Medicine and Dentistry of New Jersey.
Sample collection and processing
Diagnostic thoracocentesis for pleural aspiration was performed. 
The volume of PF collected from each patient ranged from 100 to 
700 mL. The collected PF was immediately processed to separate 
the cell-free PF, which was subsequently stored in aliquots at 
–70°C and thawed at the time of cytokine assays. Cells/CMM 
ranged from 15 to 230 in the TB group and from 150 to 700 in 
the NTB group.
Measurement of cytokines and soluble FasL
We assayed the various secretory cytokines in PF of both the 
groups using the cytometric bead array (CBA) (BD Biosciences 
Pharmingen, San Diego, CA, USA). The human cytokine kit-II 
was used to quantify the levels of IFN-γ, TNF-a, IL-4, and IL-10 
according to the manufacturer’s instructions. Briefly, 50 mL of 
standard or sample was mixed with 50 mL of premixed capture 
beads and 50 mL of PE-labeled detection reagent. After 3 hours 
of incubation at room temperature, excess of detection reagent 
was removed by washing and the samples were analyzed on FACS 
using the CBA software from BD Biosciences Pharmingen. The 
concentrations of samples were calculated by extrapolating the 
mean fluorescence intensity (MFI) on the respective standard 
curves. The lower and upper detection limits were 20 and 5,000 
pg/mL for these cytokines. The IL-6, TGF-b, IL-12p40, IL-1b, 
and soluble FasL levels were measured by ELISA (R & D Systems, 
Minneapolis, MN, USA). The samples were diluted (1 in 5) with 
assay diluent for all cytokines except IL-6 (1 in 50) and TGF-b (1 in 
10). The latent TGF-b present in the samples was acid activated (2.5 
N acetic acid/10 M urea), mixed well, incubated and neutralized 
with base (2.7 N NaOH/1 M HEPES), and subsequently used for 
the assay of TGF-b. The cytokine concentrations in specimens 
were determined by referring to a standard curve generated with 
standards. The average of the duplicate readings was taken as 
the final concentration and expressed as pg/mL or ng/mL, as 
appropriate. The assay ranges (in pg/mL) for cytokine ELISA 
were as follows: IL-6 (4.7–300), TGFb (62.5–4,000), IL-12p40 
(31.2–2,000), IL-1b (3.6–250), and sFasL (31.25–2,000).
Mononuclear cell preparation
Pleural fluid mononuclear cells (PFMC) were isolated from the 
PF by Ficoll–Hypaque (Amersham Biosciences, Uppsala, Sweden) 
density gradient centrifugation at 1800 rpm for 30 minutes. The 
cells were then washed with HBSS (BioWhittaker, Petit Rechain 
Belgium) and RPMI 1640 (Sigma Chemical Co, St. Louis, MO, 
USA) at 1,500 rpm for 10 minutes. The PFMC were reconstituted 
in RPMI 1640 with 10% FCS to get 1 × 106 cells/mL. The viability 
of the cells was assessed by the trypan blue exclusion method.
Purification of CD2+ and CD14+ cells
The CD2+ T cells and CD14+ monocytes were isolated from fresh 
20 × 106 PFMC by positive selection using anti-CD2- and anti-
CD14-conjugated magnetic microbeads and purified using MACS 
column according to the manufacturer’s instruction (Miltenyi 
Biotech, Auburn, CA, USA). The resulting cell population was 
>95% pure, as assessed by flow cytometric analysis using anti-
CD3, -CD4, and -CD14 antibodies.
Spontaneous and induced apoptosis
The 48-well culture plates (Sigma-Aldrich, St. Louis, MO, USA) 
were prepared for the initial stimulation of CD2-purified T cells by 
coating wells with 100 mL of PBS containing anti-CD3 (1 mg/mL) 
for 2 hours at room temperature and washed with Ca2+/Mg2+-free 
PBS. The wells were seeded with 1 × 106 cells/mL and incubated 
for 4 hours at 37°C. The spontaneous and induced apoptosis were 
measured using APO LOGIX kit (Cell Technologies, Mountain 
View, CA, USA). The cells were treated with 10 mL of  30×  working 
dilution of FAM-peptide-FMK 1 hour before termination. The 
cells were washed and acquired on flow cytometer. The uninduced 
control gave the spontaneous apoptosis.
Expression of costimulatory molecule
The CD14-purified monocytes from the PF or THP-1 cells (human 
macrophage cell line) were directly labeled with anti-human 
CD14-FITC, CD80-PE, and CD86-PE-Cy5 (BD Biosciences) and 
incubated at 4°C for 30 minutes. The stained cells were washed 
twice with 1X PBS and fixed with 1% paraformaldehyde. The 
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specificity of the staining technique was assessed using nonspecific 
isotype-matched control. The THP-1 cells were reacted with 
CD80-PE and CD86-APC (BD Biosciences). The pleural cells 
were analyzed on FACSCallibur (BD Biosciences) using the Cell 
quest pro software, and the THP-1 cells were analyzed on LSR2 
(BD Biosciences) using the DiVa software.
Statistical analysis
Data are represented as bar graphs in the figures. Comparisons 
between groups were done by an unpaired t-test using GraphPad 
Prism (version 4; La Jolla, CA, USA). p <0.05 was considered to 
be statistically significant.
Results
Augmented Th1 cytokines in TB pleurisy
We first determined the levels of the Th1 cytokines IFN-γ and 
IL-12p40 in pleural effusions and found that the levels of both 
these cytokines were significantly upregulated in the TB group 
compared to the NTB group (Figure 1). These data support and 
extend previous observations of Th1 activation in the pleural 
cavity in TB patients.15,18,21–23 The absence of Th1 cells in the NTB 
group provided us an opportunity to examine whether apoptosis is 
confined to the Th1 phenotype in vivo, akin to what was previously 
observed by us in vitro.24
To confirm that inflammation was present in the pleura 
of NTB patients, we also examined the pleural effusion for the 
levels of the proinflammatory cytokines TNF-a, IL-1b, and IL-6. 
In contrast to what was observed with the Th1 cytokines, both 
groups exhibited similar levels of all three proinflammatory 
cytokines tested (Figure 2). This suggests that inflammation is 
present in both TB and NTB pleural cavity, but the former is 
Th1 dominant.
Similar pattern of spontaneous and activation-induced 
apoptosis of T cells isolated from TB and NTB PF
T cells from both groups exhibited spontaneous apoptosis, and 
furthermore, CD3 stimulation enhanced activation-induced 
apoptosis in both groups (Figure 3). These data, in contrast to the 
in vitro observations,24 indicate that apoptosis is not Th1 specific 
under in vivo conditions of activation.
To further understand the cause of the enhanced T cell apoptosis, 
we determined the level of sFasL, a known mediator of apoptosis, in 
the pleural effusion from the two groups. Despite similar apoptosis 
profiles, sFasL level was significantly higher in TB compared to 
NTB PF (Figure 4). These data indicate that other factors may be 
responsible for the enhanced apoptosis seen in NTB PF.
Low CD80 expression on CD14+ cells isolated from TB and 
NTB PF
Although the antigen specificity of the T cells in the NTB PF is not 
known, we argued that antigen presentation to T cells in the absence 
of second signals from CD80 and CD86 may be the cause of enhanced 
T-cell apoptosis in the inflamed pleura. The expression of CD80 and 
CD86 was therefore analyzed on CD14+ cells isolated from the PF of 
TB and NTB patients. As shown in Figure 5, the majority of CD14+ 
cells isolated from the PFs of both TB and NTB patients expressed 
CD86, while only 10% of the cells from both groups expressed CD80. 
The percentage of cells expressing CD80 is significantly upregulated 
in monocyte cultures when exposed to inflammatory stimuli.25 Thus, 
despite elevated levels of inflammatory cytokines, TNF-a and IFN-γ 
in the pleural effusions, CD80 expression was not upregulated in the 
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Figure 1. Unequal expression of IFN- and IL-12p40 in tuberculous and 
nontuberculous pleuritis. Pleural fluid levels of IFN-γ and IL-12p40 was assessed 
by cytometric bead array and ELISA, respectively. The levels were quantified in 27 
tuberculous (TB) and 18 nontuberculous (NTB) patients and the concentration of 
the cytokines is expressed in pg/mL. Data are represented as mean ± standard error 
of mean (SEM). *Represents p < 0.05.
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Figure 2. Equivalent level of proinflammatory cytokines in TB and NTB 
pleural fluid. The mean levels of the cytokines IL-1b and IL-6 were assayed by 
ELISA and TNF-a by cytometric bead array in pleural fluid of 27 tuberculous (TB) 
and 18 nontuberculous (NTB) subjects. Only the IL-6 estimation was carried after 
1:50 dilution of the samples in reagent diluent and its concentration is expressed in 
ng/mL . The bars represent mean ± standard error of mean (SEM).
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CD14+ cells derived from both groups, suggesting an association of 
low CD80 expression with enhanced T-cell apoptosis.
TGF-b regulates CD80 expression
To gain insight into the mechanism behind the lack of CD80 
upregulation on CD14+ cells, we examined the levels of TGF-b, 
IL-10, and IL-4, which are the known downregulators of CD80 
and CD86 expression. In both groups, equivalent amount of IL-4, 
IL-10, and TGF-b accumulated in the PF but the level of TGF-b 
was significantly elevated (Figure 6). To determine if there was 
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Figure 3. Spontaneous and activation-induced apoptosis of T cells isolated 
from TB and NTB pleural fluid. Induced apoptosis of CD2 purified T cells from 
pleural fluid was assessed by pulsing with 0.5 mg of anti-CD28 (0.5 mg/mL) and 
cultured with anti-CD3 (1 mg/mL). The spontaneous and anti CD3/CD28-induced 
apoptosis was evaluated by measuring the cleaved caspase proteins after incubation 
with FAM-peptide-FMK by flow cytometry. The assay was carried out in 18 tuberculous 
(TB) and 9 nontuberculous (NTB) subjects and the results are expressed as mean 
± standard error of mean (SEM).
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Figure 4. Soluble FasL levels in tuberculous and nontuberculous pleural 
fluid. The soluble FasL in pleural fluids was estimated by ELISA in 27 tuberculous 
(TB) and 18 nontuberculous (NTB) subjects. The concentration is expressed in 
pg/mL and the data are represented as mean ± standard error of mean (SEM). 
*Represents p < 0.05.
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Figure 5. Expression of costimulatory molecules on CD14+ cells isolated 
from pleural fluid of tuberculous and nontuberculous pleuritis. The CD14 
purified monocytes from the pleural fluid were directly labeled with anti-human 
CD14-FITC, CD80-PE, and CD86-PE-Cy5 and their expression were assessed by 
flow cytometry in 22 tuberculous (TB) and 16 nontuberculous (NTB) subjects. The 
bars represent the mean percentage expression of CD80 and CD86 molecules on 
monocytes ± standard error of mean (SEM).
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Figure 6. The expression of immunosuppressive cytokines in tuberculous 
and nontuberculous pleural fluid. The mean levels of the cytokines IL-4 and 
IL-10 were assayed by CBA and TGF-b by ELISA in pleural fluid of 27 tuberculous 
(TB) and 18 non tuberculous (NTB) subjects. The estimation of TGF-b was carried 
after 1:10 dilution of the samples in reagent diluent. The bars represent mean ± 
standard error of mean (SEM).
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a causal relationship between the reduced CD80 expression and 
elevated TGF-b level in the PF, we examined in vitro whether 
TGF-b downmodulated the expression of CD80. This was tested 
in the human macrophage cell line, THP-1. Examination by 
flow cytometry showed that only 1% of unstimulated THP-1 
cells expressed CD80, and that the expression increased to 51% 
following stimulation with LPS, but to only 20% when stimulated 
in the presence of TGF-b (Figure 7, upper three panels). In contrast, 
the THP-1 cells exhibited constitutive CD86 expression, and this 
was not further modulated by LPS stimulation, with or without 
TGF-b (Figure 7, lower three panels). The MFI also paralleled the 
percentage of positive cells for the two costimulatory molecules 
under the different stimulating conditions (Figure 7). These data 
suggest that TGF-b abrogates upregulation of CD80 expression 
on macrophages, while not interfering with the constitutively 
expressed CD86 molecules.
Discussion
In this study, we show that while both TB and NTB effusions are 
characterized by a strong inflammatory response, it is only TB 
effusions that exhibit a strongly Th1-polarized response, with 
significantly high levels of IL-12 and IFN-γ, consistent with 
previous data.26–28 The cellular source of the IFN-γ in TB effusions 
could be both Th1 and NK cells, and most likely driven by the 
presence of IL-12 in the effusions. In addition, M. tuberculosis can 
directly ligate TLRs on NK cells and induce IFN-γ secretion,29 
providing an additional means to enhance IFN-γ secretion 
from NK cells. Despite 
the expression of a strong 
proinflammatory response, 
the NTB effusions showed 
neither a Th1- nor a Th2-
dominant cytokine milieu. 
A similar observation was 
made in a study comparing 
malignant and tuberculous 
pleurisies, where PF from 
malignant patients lacked 
IFN-γ  expression.30 However, 
addition of IL-12 and IL-18 
to T cells explanted in vitro 
from malignant PF enhanced 
their IFN-γ production.30 In 
the present study, we did not 
examine whether external 
factors would enhance 
IFN-γ secretion from T cells 
derived from NTB effusions. 
Nevertheless, it raises an 
interesting possibility that T 
cells in malignant effusions 
are Th1-like and therefore 
susceptible to spontaneous 
and induced apoptosis, akin 
to fully differentiated Th1 
cells present in TB effusions.
Another striking diffe-
rence in the pleural effusions 
derived from the two 
groups of patients was the 
increased level of sFASL only 
in TB effusions, providing 
a mechanism for several previous studies that have reported 
enhanced T-cell apoptosis in TB PF cells. A recent study similarly 
reports that sFasL is detectable only in tuberculosis pleurisy and 
not in other conditions of clinical pleurisy.31 However, we observed 
that despite low sFASL in NTB effusions, cells derived from these 
sites exhibited both spontaneous and induced apoptosis. This 
suggests that apoptotic death of  T cells is an important regulator of 
inflammation that is caused not only from bacterial infection but 
also from other nonbacterial factors, and furthermore, mediators 
other than sFasL may contribute to the observed apoptosis.
Previously, we had reported that Th1 cells are highly 
susceptible to activation-induced apoptosis when costimulation 
from antigen-presenting cells is lacking,24 and provision of 
costimulation by ligation of CD28 molecules rescued them 
from activation-induced apoptosis.32 Furthermore, murine 
macrophages infected with M. tuberculosis express reduced 
levels of costimulatory molecules.33 Based on these studies, we 
argued that the enhanced apoptosis occurring in TB pleurisy is 
not due to increased expression of mediators of apoptosis but 
due to attenuation of costimulation from macrophages. CD80 
and CD86 are two important costimulatory molecules that 
T cells engage on antigen-presenting cells, and the former is 
upregulated following macrophage activation by TLR agonists 
and TNF-a, while the latter is constitutively expressed.34 
Examination of costimulatory molecules on purified CD14+ 
macrophages revealed that CD86 was expressed by a majority 
of the cells, while only a small percentage expressed CD80. So 
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Figure 7. Effect of TGFb on CD80 and CD86 expression by LPS-stimulated macrophages. A total of 1 × 106 THP-1 cells were 
pretreated with 1 ng/mL of TGF-b (BD Biosciences) for 2 hours, followed by 1 mg/mL LPS (Sigma) for 24 hours. Following which 
the cells were harvested, reacted with PE-conjugated anti-CD80 and CD86 antibodies (black-colored histogram) and isotype control 
(gray-colored histogram), and analyzed by flow cytometry for CD80 and CD86 expression. MFI = mean fluorescence intensity. The 
data are representative of one of three individual experiments.
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it is very likely that in vivo, in the pleural compartment, the 
CD80-attenuated macrophages do not provide appropriate 
second signal to T cells, which results in their enhanced 
apoptosis.
Findings from the present study and that of others35 
demonstrate that TGF-b interferes with CD80 upregulation on 
antigen-presenting cells, suggesting that in vivo also this cytokine 
may be responsible for the attenuated CD80 expression on 
macrophages in both TB and NTB pleural effusions. Although, 
lower levels of IL-4 and IL-10 are detected in the pleural effusions, 
it is nevertheless possible that these two cytokines have significant 
biological activity in vivo and work together with TGF-b to alter 
CD80 expression on macrophages. Consistent with TGF-b’s 
role in T-cell apoptosis, Hirsch and colleagues also report that 
excessive expression of this cytokine along with enhanced levels of 
TNF and FasL predisposes CD4 T cells derived from TB patients 
to apoptosis.36
Together, the data presented here suggest that a deviation 
in the expression of CD80 molecules most likely underlies 
the enhanced T cell apoptosis seen in pleural effusions. 
Interestingly, the requirement for second signal to resist 
apoptosis is not confined to the Th1 subtype, since T cells from 
NTB that are not Th1 polarized also undergo apoptosis under 
conditions of diminished CD80 expression on macrophages. 
These findings raise the possibility that apoptosis of T cells in 
vivo during an inflammatory response in the lung may be a 
way to prevent excessive inflammation and protect the host 
from tissue damage, rather than an immune deviation strategy 
of M. tuberculosis.
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